张豆豆谈婆媳关系

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_蜘蛛资讯网

rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expec

vious projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-th

当前文章：http://728q.cenluqi.cn/o7e/4r2w.doc

发布时间：00:23:10